An RCT for the evaluation of the effects of Real Time Medication Monitoring (RTMM) on improving medication adherence in diabetes type 2 patients in the Netherlands.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON19988

Enrollment

210

Registered

2009-06-25

Start date

2008-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus type 2, medication adherence

Interventions

The intervention consists of providing RTMM with SMS reminders to non-adherent diabetes type 2 patients to improve their adherence to oral antidiabetics. Two experimental groups and one control group

Eligibility

Inclusion criteria

Inclusion criteria: 1. Using oral antidiabetic medication for at least one year; 2. Having an adherence level of <80% according to pharmacy refill data from the year preceding the intervention; 3. Aged between 18 and 65 years; 4. Last prescription (theoretically) until at least two months before the start of the intervention; 5. Understanding/speaking the Dutch language; 6. Using a mobile telephone.

Exclusion criteria

Exclusion criteria: 1. Age 65 years; 2. Not understanding/speaking Dutch.

Design outcomes

Primary

Measure	Time frame
Adherence to oral antidiabetic medication.	—

Secondary

Measure	Time frame
1. Changes in patients' beliefs about medicines (BMQ-Specific); 2. Illness perceptions (Brief IPQ); 3. Levels of bloodglucose (HbA1c).	—

Contacts

Public ContactM. Vervloet

P.O. Box 1568

M.Vervloet@nivel.nl+31302729700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)